Press Releases

With the Potential to Revolutionize Personalized Health, Range Biotechnologies Receives $5.2 Million in Seed Funding Led by TechBio-Focused ARTIS Ventures. Range Bio seeks to enable better diagnostics and faster drug development by unlocking translational proteomics

Brian Gormley of The Wall Street Journal spoke with ARTIS Partner Ameena El-Bibany to discuss their portfolio companies in the field of protein research, including Range Biotechnologies and Glyphic Biotechnologies. #techbio #biotech #proteinresearch